Education
About Us
Working with TipRanks
Follow Us
Integral Diagnostics Ltd. (AU:IDX)
ASX:IDX
RESEARCH TOOLSreports
Total Valuation
Integral Diagnostics Ltd. has a market cap or net worth of AU$793.27M. The enterprise value is AU$939.91M.
Market CapAU$793.27M
Enterprise ValueAU$939.91M
Share Statistics
Integral Diagnostics Ltd. has 372.43M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding372.43M
Owened by Insiders0.23%
Owened by Instutions
Financial Efficiency
Integral Diagnostics Ltd.’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per EmployeeAU$237,580.678
Profits Per Employee-AU$30,702.58
Employee Count1,977
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Integral Diagnostics Ltd. is ―. Integral Diagnostics Ltd.’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Integral Diagnostics Ltd. had revenue of AU$469.70M and earned -AU$60.70M in profits. Earnings per share was -AU$0.26.
RevenueAU$469.70M
Gross ProfitAU$104.04M
Operating IncomeAU$43.03M
Pretax Income-AU$57.07M
Net Income-AU$60.70M
EBITDA12.33M
Earnings Per Share (EPS)-0.26
Cash Flow
In the last 12 months, operating cash flow was AU$66.16M and capital expenditures -AU$23.88M, giving a free cash flow of AU$42.28M billion.
Operating Cash FlowAU$66.16M
Free Cash FlowAU$42.28M
Free Cash Flow per ShareAU$0.11
Dividends & Yields
Integral Diagnostics Ltd. pays an annual dividend of AU$0.06, resulting in a dividend yield of 2.67%
Dividend Per ShareAU$0.06
Dividend Yield2.67%
Payout Ratio70.37%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta>-0.01
52-Week Price Change-1.30%
50-Day Moving Average2.52
200-Day Moving Average2.70
Relative Strength Index (RSI)40.72
Average Volume (3m)2.38M
Important Dates
Integral Diagnostics Ltd. upcoming earnings date is Sep 1, 2025, TBA.
Last Earnings DateFeb 25, 2025
Next Earnings DateSep 1, 2025
Ex-Dividend DateMar 6, 2025
Financial Position
Integral Diagnostics Ltd. as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Integral Diagnostics Ltd. has paid AU$3.56M in taxes.
Income TaxAU$3.56M
Effective Tax Rate―
Enterprise Valuation
Integral Diagnostics Ltd. EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Integral Diagnostics Ltd. has AU$42.44M in cash and marketable securities with AU$357.80M in debt, giving a net cash position of AU$315.36M billion.
Cash & Marketable SecuritiesAU$42.44M
Total DebtAU$357.80M
Net CashAU$315.36M
Net Cash Per ShareAU$0.85
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Integral Diagnostics Ltd. is AU$3.19, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price TargetAU$3.19
Price Target Upside49.77%
Analyst ConsensusStrong Buy
Analyst Count10
Revenue Growth Forecast7.83%
EPS Growth Forecast